3Stelzer GT,Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Am N Y Acad Sci, 1993,677: 265-280.
4Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color-analysis. Am J Clin Pathol, 1993,100:534-540.
5Pui CH, Behm FG. Siugh B, et al. Helerogeueitv of presenting features and their relatiou to treatmeut outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood, 1990.75: 174-179.
6Pui CH, Schell MJ, Raimondi SC, et al. Myeloid-amtigen expression in childhood acute lymphoblaslic leukenua. N Engl J Med, 1991,325: 1378-1382.
7Ratei R, Sperling C. Karawajew L, el al. Immuophenotype and clinical charaeteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Ann Henmtol, 1998,77: 107-114.
8Hanu JM, Richards SM, Eden OB, et al. Analvsis of the immnunopheuotype of children treated on the Medical Research Gouncil U nited Kingdom acute lymphoblastic leukemia trial \l (MRC UKALL \). Leukemia,1998, 12: 1249-1255.
9Garcia JA, Monteserin MC, Delgado I, et al. Aberrant immunophenotype immunophenotypes detected by flow cytometry in acute lymphoblastic leukemia. Leukemia Lymphoma, 2000,36: 275 -284.
